BVS logo

Bioventus (BVS) Revenue

Annual Revenue

$512.35 M
+$228.00 K+0.04%

December 31, 2023


Summary


Performance

BVS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBVSprofitabilitymetrics:

Quarterly Revenue

$138.96 M
-$12.25 M-8.10%

September 28, 2024


Summary


Performance

BVS Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$555.06 M
+$18.17 M+3.38%

September 28, 2024


Summary


Performance

BVS TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBVSprofitabilitymetrics:

BVS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.0%+2.6%+8.3%
3 y3 years+59.5%+6.6%+28.8%
5 y5 years+60.5%+6.6%+28.8%

BVS Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+18.9%-8.1%+18.5%at high+28.8%
5 y5-yearat high+59.5%-8.1%+139.5%at high+469.0%
alltimeall timeat high+120.5%-8.1%+160.4%at high+940.2%

Bioventus Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$138.96 M(-8.1%)
$555.06 M(+3.4%)
Jun 2024
-
$151.22 M(+16.8%)
$536.89 M(+2.7%)
Mar 2024
-
$129.46 M(-4.4%)
$522.74 M(+2.0%)
Dec 2023
$512.35 M(+0.0%)
$135.42 M(+12.1%)
$512.35 M(+1.9%)
Sep 2023
-
$120.79 M(-11.9%)
$502.76 M(-1.5%)
Jun 2023
-
$137.07 M(+15.1%)
$510.62 M(-0.6%)
Mar 2023
-
$119.06 M(-5.4%)
$513.89 M(+0.3%)
Dec 2022
$512.12 M(+18.8%)
$125.83 M(-2.2%)
$512.12 M(-0.9%)
Sep 2022
-
$128.66 M(-8.3%)
$516.70 M(+4.0%)
Jun 2022
-
$140.33 M(+19.6%)
$496.93 M(+6.5%)
Mar 2022
-
$117.29 M(-10.1%)
$466.41 M(+8.2%)
Dec 2021
$430.90 M
$130.41 M(+19.8%)
$430.90 M(+8.0%)
Sep 2021
-
$108.89 M(-0.8%)
$399.07 M(+6.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
$109.82 M(+34.3%)
$376.09 M(+16.0%)
Mar 2021
-
$81.78 M(-17.1%)
$324.29 M(+1.0%)
Dec 2020
$321.16 M(-5.6%)
$98.59 M(+14.8%)
$321.16 M(+0.3%)
Sep 2020
-
$85.91 M(+48.1%)
$320.12 M(+36.7%)
Jun 2020
-
$58.02 M(-26.2%)
$234.22 M(+32.9%)
Mar 2020
-
$78.64 M(-19.4%)
$176.20 M(+80.6%)
Dec 2019
$340.14 M(+6.6%)
$97.55 M(+49.2%)
$97.55 M(+49.2%)
Dec 2018
$319.18 M(+25.8%)
-
-
Mar 2016
-
$65.40 M(+22.6%)
$65.40 M(+22.6%)
Dec 2015
$253.65 M(+4.4%)
-
-
Mar 2015
-
$53.36 M
$53.36 M
Dec 2014
$242.89 M(+4.5%)
-
-
Dec 2013
$232.38 M
-
-

FAQ

  • What is Bioventus annual revenue?
  • What is the all time high annual revenue for Bioventus?
  • What is Bioventus annual revenue year-on-year change?
  • What is Bioventus quarterly revenue?
  • What is the all time high quarterly revenue for Bioventus?
  • What is Bioventus quarterly revenue year-on-year change?
  • What is Bioventus TTM revenue?
  • What is the all time high TTM revenue for Bioventus?
  • What is Bioventus TTM revenue year-on-year change?

What is Bioventus annual revenue?

The current annual revenue of BVS is $512.35 M

What is the all time high annual revenue for Bioventus?

Bioventus all-time high annual revenue is $512.35 M

What is Bioventus annual revenue year-on-year change?

Over the past year, BVS annual revenue has changed by +$228.00 K (+0.04%)

What is Bioventus quarterly revenue?

The current quarterly revenue of BVS is $138.96 M

What is the all time high quarterly revenue for Bioventus?

Bioventus all-time high quarterly revenue is $151.22 M

What is Bioventus quarterly revenue year-on-year change?

Over the past year, BVS quarterly revenue has changed by +$3.54 M (+2.61%)

What is Bioventus TTM revenue?

The current TTM revenue of BVS is $555.06 M

What is the all time high TTM revenue for Bioventus?

Bioventus all-time high TTM revenue is $555.06 M

What is Bioventus TTM revenue year-on-year change?

Over the past year, BVS TTM revenue has changed by +$42.72 M (+8.34%)